Practical Inpatient Use of CGM, Insulin Pumps, and AID Systems: Key Recommendations from an International Position Statement

Introduction and Context

Hospitals increasingly encounter patients who manage diabetes with continuous glucose monitoring (CGM), insulin pumps, and automated insulin delivery (AID) systems. These technologies—once confined to outpatient care—offer real‑time glycemic data and precise insulin delivery that can improve glucose control. But their inpatient use raises clinical, operational, safety, and legal questions: when can devices be continued, when should they be stopped, how should staff interpret CGM metrics in the hospital setting, and how should data be integrated into electronic health records (EHRs)?

The international position statement led by Olsen MT and colleagues (Diabetes Care, 2026) responds to this urgent need for actionable, hospital‑facing guidance. It synthesizes expert consensus from endocrinology, inpatient medicine, nursing, biomedical engineering, and health systems leadership to produce practical recommendations for non‑critically ill adults. This article summarizes those core recommendations and highlights operational implications for clinicians and hospital systems.